InterCure announced that it intends to effect a one-for-five reverse split of the company’s ordinary shares, no par value per share. The ordinary shares will continue to trade on the Nasdaq Global Market under the existing symbol (INCR), and will begin trading on a split-adjusted basis when the market opens on August 24. The new CUSIP number for the ordinary shares following the reverse share split will be M549GJ368.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INCR:
- InterCure Shareholders Approve Proposal at August 11 Extraordinary Meeting
- Intercure Details Voting Procedures for August 11 Extraordinary Shareholder Meeting
- InterCure Calls August 12 EGM to Approve 5‑for‑1 Reverse Share Split
- InterCure Secures NIS 22 Million Private Placement to Fund Global Medical Cannabis Expansion